Maternal immunization in Malawi: A mixed methods study of community perceptions, programmatic considerations, and recommendations for future planning. Issue 32 (26th July 2019)

• Record Type: Journal Article
• Authors: Fleming, Jessica A.; Munthali, Alister; Ngwira, Bagrey; Kadzandira, John; Jamili-Phiri, Monica; Ortiz, Justin R.; Lambach, Philipp; Hombach, Joachim; Neuzil, Kathleen M.; Stepanchak, Maria; Bhat, Niranjan
• Is Part Of: Vaccine. Volume 37:Issue 32(2019)
• Page Start: 4568
• Page End: 4575
• Publication Date: 2019-07-26
• Subjects: Maternal immunization -- Malawi -- Maternal tetanus toxoid and maternal influenza vaccine -- Operational research; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2019.06.020
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: Health workers and community members expressed high acceptance of maternal vaccines. Malawi's strong tetanus vaccine delivery system may benefit new maternal vaccines. Community members and policy makers have low awareness of influenza disease burden. Abstract: Background: Safe, effective vaccines are given to pregnant women to protect their infants and/or themselves against certain infectious agents; however, apart from tetanus vaccination, maternal immunization in low- and middle-income countries (LMICs) remains low. Tetanus toxoid vaccine is integrated into antenatal care services in Malawi with high coverage and provides an opportunity to identify factors that facilitate successful immunization delivery to pregnant women in LMICs. Methods: PATH and the University of Malawi's Centre for Social Research conducted a mixed-methods study in 2015 to document community perceptions of maternal immunization, using tetanus vaccine as an example, and to identify factors perceived to be important to successfully introducing other maternal vaccines, such as influenza vaccine, in Malawi. We conducted 18 focus group discussions with pregnant and recently pregnant women and their family members and 76 semi-structured interviews with pregnant and recently pregnant women, community leaders, health workers, public health program managers, non-governmental partners, and policy makers. Results: We identified factors perceived to support the introduction of new maternal vaccines, including strong maternal vaccine acceptance in the community, an existing strategy for maternal tetanus vaccine delivery, and positive health workers' views about the introduction of additional maternal vaccines. Potential challenges to adoption and acceptance included identifying and tracking the target population and monitoring adverse events, and the need to ensure operational capacity of the health system to support the introduction and wide-scale use of an additional vaccine. For influenza vaccine specifically, additional challenges included limited awareness of influenza disease and its low prioritization among health needs. Conclusions: Lessons from the successful delivery of maternal tetanus immunization in Malawi may be informative for similar countries considering new vaccines for pregnant women or striving to optimize the delivery of those currently provided.